Header Logo

Connection

Yihe Daida to Hepatitis C, Chronic

Back to Details
This is a "connection" page, showing publications Yihe Daida has written about Hepatitis C, Chronic.
Yihe Daida
Connection Strength
1.970
Hepatitis C, Chronic
  1. Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis?C and Cirrhosis. Adv Ther. 2024 Feb; 41(2):744-758.
    View in: PubMed
    Score: 0.226
  2. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat. 2023 09; 30(9):746-755.
    View in: PubMed
    Score: 0.218
  3. The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017. Clin Infect Dis. 2021 09 07; 73(5):891-894.
    View in: PubMed
    Score: 0.192
  4. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol. 2021 01; 55(1):77-83.
    View in: PubMed
    Score: 0.183
  5. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis. J Gastrointest Cancer. 2020 Jun; 51(2):461-468.
    View in: PubMed
    Score: 0.176
  6. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. J Viral Hepat. 2019 10; 26(10):1210-1217.
    View in: PubMed
    Score: 0.165
  7. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
    View in: PubMed
    Score: 0.160
  8. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Aliment Pharmacol Ther. 2019 03; 49(5):599-608.
    View in: PubMed
    Score: 0.160
  9. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018 06; 32(2):253-268.
    View in: PubMed
    Score: 0.153
  10. Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States. J Viral Hepat. 2018 08; 25(8):952-958.
    View in: PubMed
    Score: 0.151
  11. Changing trends in complications of chronic hepatitis C. Liver Int. 2018 02; 38(2):239-247.
    View in: PubMed
    Score: 0.144
  12. Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunities. Am J Manag Care. 2019 08; 25(8):369-374.
    View in: PubMed
    Score: 0.042

© 2024 Kaiser Permanente